The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 3-8A ATL: Clinical practice

Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Yoshitaka Imaizumi (Department of Hematologuy, Nakasaki University Hospital, Japan)

Shigeki Ito1, Masako Iwanaga2, Kisato Nosaka3, Kenji Ishitsuka4, Yoshitaka Imaizumi5, Kaoru Uchimaru6, Atae Utsunomiya7, Yoshiki Tokura8, Kensei Tobinai9, Kazuya Shimoda10, Sawako Nakachi11, Toshiki Watanabe12, Kunihiro Tsukasaki13 (1.Dept. of Clin Oncol., Iwate Medical University., Morioka, Japan, 2.Dept. of Frontier Life Science, Nagasaki University, Nagasaki, 3.Dept. of Hematology, Kumamoto University School of Medicine, Kumamoto, 4.Dept. of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, 5.Dept. of Hematology, Nagasaki University Hospital, Nagasaki, 6.Laboratory of Tumor Cell Biology, The University of Tokyo, Tokyo, 7.Dept. of Hematology, Imamura General Hospital, Kagoshima, 8.Dept. of Dermatology, Hamamatsu University, Shizuoka, 9.National Cancer Centre Hospital, Tokyo, 10.Dept. of Gastroenterology and Hematology, University of Miyazaki, Miyazaki, 11.Second Dept. of Internal Medicine, University of Ryukyus Hospital, Okimawa, 12.Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, 13.Dept. of Hematology, International Medical Center, Saitama Medical University, Saitam)

Junya Makiyama1, Seiichiro Kobayashi2, Eri Watanabe3, Tomohiro Ishigaki4,5, Toyotaka Kawamata1, Makoto Nakashima6, Makoto Yamagishi6, Kazumi Nakano6, Arinobu Tojo1,2, Toshiki Watanabe7, Kaoru Uchimaru1,6 (1.Dpt. Hematology/Oncology, IMSUT Hospital, Tokyo, Japan, 2.Division of Molecular Therapy, IMSUT, 3.IMSUT clinical flow cytometry laboratory, 4.Dpt. Laboratory Medicine, IMSUT Hospital, 5.Division of Stem Cell Therapy, IMSUT, 6.Graduate School of Frontier Sciences, The University of Tokyo, 7.Dpt. Advanced Medical Innovation, St. Marianna University School of Medicine)

Sawako Nakachi1, Satoko Morishima1, Masahiro Okada2, Yurika Agarie3, Sachie Uchibori1, Sakiko Kitamura1, Shouhei Tomori1, Taeko Hanashiro1, Natsuki Shimabukuro1, Keita Tamaki1, Iori Tedokon1, Kazuho Morichika1, Yukiko Nishi1, Kennosuke Karube4, Takuya Fukushima5, Hiroaki Masuzaki1 (1.Second Department of Internal Medicine, Ryukyus Univ., 2.Department of Radiology, Nihon University School of Medicine, 3.Department of Radiology, Heartlife Hospital, Okinawa, Japan, 4.Department of Pathology and Cell Biology, Ryukyus Univ., 5.Laboratory of Hematoimmunology, Ryukyus Univ.)

Ayumu Kubota1, Nobuaki Nakano1, Takayoshi Miyazono1, Masahito Tokunaga1, Jun Odawara1, Tomohisa Tabuchi1, Yuka Shimoda2, Kentaro Yonekura3, Hirotoshi Nishida4, Shogo Takeuchi1, Yoshifusa Takatsuka1, Yoshikiyo Ito1, Atae Utsunomiya1 (1.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 2.Department of Neurology, Imamura General Hospital, Kagoshima, Japan, 3.Department of Dermatology, Imamura General Hospital, Kagoshima, Japan, 4.Department of Radiology, Imamura General Hospital, Kagoshima, Japan)